Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19

Overview of attention for article published in Neurological Research and Practice, June 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 8,665 followers.

@ctrssierra No but there is this: https://t.co/OWmjIZ1biB

10 Jan 2023

Reply Repost Favourite

Case report (n=1): 6 months after mild COVID-19, long-lasting cognitive impairment along with persistent cerebrospinal fluid anti-SARS-CoV-2 antibodies. https://t.co/z3hclDarRi

19 Jan 2022

Reply Repost Favourite

@PSHolstein @RealKumberger @NatalieGrams 1/ Ich bin vorbereitet ;-), siehe die Verlinkung zum Blog. Und ich nutze pubmed. Und die Antwort ist, es ist nicht sonderlich neuroinvasiv. Es gibt Einzelfallberichte, wie diesen hier: https://t.co/lkGn1zfsVP

29 Aug 2021

Reply Repost Favourite

Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19 https://t.co/IWj09DhOs8

21 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.